T50® - The first blood test to assess Calcification-related Cardiovascular Risk
Clinical Utility
T50 improves patient care in CKD 5 / 5D
Further information for:
PATIENTS
PROFESSIONALS

Research Utility
T50 improves clinical research
Further information for:
RESEARCHERS

PROBLEM
Most kidney patients still suffer and die
from cardiovascular disease.
SOLUTION
Calciscon T50 is a unique blood test that identifies
high-risk patients, and also tells the physician whether
the current therapy needs to be optimized.
T50 - THE VALUE WHICH
REALLY MATTERS IN
CHRONIC KIDNEY DISEASE!
NEWS
ABOUT US
Our team advances the quality of clinical care
with novel diagnostics assessing calcification progression,
with an initial focus on chronic kidney disease.



LEARN MORE
Would you like to know more about
Calciscon or our products?
Then please contact us. We look forward to hearing from you.


CALCISCON AG
Aarbergstrasse 46,
2503 Biel | Bienne.
Switzerland
Phone: 0041 32 530 88 60
Email: info@calciscon.com
CONTACT
© 2022 by CALCISCON | Privacy Policy